Furthermore, the significant association with radiological progression of anti-CarP IgG in ACPA-negative RA patients strongly suggested that anti-CarP antibody can also be used as a biological marker to diagnose a high risk RA population (196). This evidence concerns the gene PRTN3 and rheumatoid arthritis.